95 Results for 2025 Outcomes Report

Pages

Therapy Access

Insights

Pharmacist Interventions Associated with a Cardiac Amyloidosis Patient Management Program

This study assesses the pharmacist impact within an ATTR-CM specialty program by characterizing documented interventions and associated outcomes.

Pages

Shields Health Solutions

Pages

Solutions

Insights

Recombinant Human Growth Hormone Therapy Clinical Outcomes at an Integrated Health System Specialty Pharmacy

This study assess the impact of a health system specialty pharmacy program on operational and clinical outcomes for patients on hGH.

News

Shields Health Solutions Brings Integrated Specialty Pharmacy Services to Baptist Health in Jacksonville

The onsite specialty pharmacy will streamline access to medications, enhance care coordination, and improve patient outcomes.

Insights

Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters

With the right partner, you can accelerate your specialty pharmacy program’s potential while retaining full ownership and staying true to your mission. Learn how.

Pages

Technology

Insights

2025 Specialty Pharmacy Outcomes

The 5th Annual Shields Specialty Pharmacy Outcomes Report is here. Featuring results from more than 2 million patients across 50+ integrated disease states and nearly 80 health system partners.

Insights

Revised 340B Rebate Model Pilot Program: What Covered Entities Need to Know for 2027

Starting January 1, 2027, the 340B landscape may shift following the Health Resources and Services Administration’s (HRSA) implementation of the revised 340B Rebate Model Pilot Program (“Pilot Program

Insights

Introducing Connected Performance: A Better Approach for Specialty Care

Improve specialty outcomes and access to therapy with Shields’ platform that combines embedded clinical expertise with AI-enabled automation and intelligent workflows to drive connected performance. 

Pages

Operational Rigor